1. Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes. (19th February 2021) Authors: Multinu, Francesco; Garzon, Simone; Weaver, Amy L; McGree, Michaela E.; Sartori, Enrico; Landoni, Fabio; Zola, Paolo; Dinoi, Giorgia; Aletti, Giovanni; Block, Matthew S; Gadducci, Angiolo; Mariani, Andrea Journal: International journal of gynecological cancer Issue: Volume 31(2021)Supplement 4 Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes. Issue 4 (19th February 2021) Authors: Multinu, Francesco; Garzon, Simone; Weaver, Amy L; McGree, Michaela E.; Sartori, Enrico; Landoni, Fabio; Zola, Paolo; Dinoi, Giorgia; Aletti, Giovanni; Block, Matthew S; Gadducci, Angiolo; Mariani, Andrea Journal: International journal of gynecological cancer Issue: Volume 31:Issue 4(2021) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant chemotherapy in early‐stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes. Issue 4 (April 2021) Authors: Multinu, Francesco; Garzon, Simone; Weaver, Amy L; McGree, Michaela E.; Sartori, Enrico; Landoni, Fabio; Zola, Paolo; Dinoi, Giorgia; Aletti, Giovanni; Block, Matthew S; Gadducci, Angiolo; Mariani, Andrea Journal: International journal of gynecological cancer Issue: Volume 31:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. Issue 7 (July 2019) Authors: Andrews, Miles C; Berry, Donald A; Block, Matthew S; Boland, Genevieve M; Bollin, Kathryn B; Carlino, Matteo S; Carvajal, Richard D; Cohen, Jonathan; Davar, Diwakar; Delman, Keith A; Dummer, Reinhard; Farwell, Michael D; Fisher, David E; Fusi, Alberto; Glitza, Isabella C; de Gruijl, Tanja D; Gyor... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: e378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Numerical studies of various Néel-VBS transitions in SU(N) anti-ferromagnets. (September 2015) Authors: Kaul, Ribhu K; Block, Matthew S Journal: Journal of physics Issue: Number 640(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers. Issue 5 (27th October 2020) Authors: Colon-Otero, Gerardo; Zanfagnin, Valentina; Hou, Xiaonan; Foster, Nathan R; Asmus, Erik J; Wahner Hendrickson, Andrea; Jatoi, Aminah; Block, Matthew S; Langstraat, Carrie L; Glaser, Gretchen E; Dinh, Tri A; Robertson, Matthew W; Camoriano, John K; Butler, Kristina A; Copland, John A; Weroha, S John Journal: ESMO open Issue: Volume 5:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers. Issue 5 (27th October 2020) Authors: Colon-Otero, Gerardo; Zanfagnin, Valentina; Hou, Xiaonan; Foster, Nathan R; Asmus, Erik J; Wahner Hendrickson, Andrea; Jatoi, Aminah; Block, Matthew S; Langstraat, Carrie L; Glaser, Gretchen E; Dinh, Tri A; Robertson, Matthew W; Camoriano, John K; Butler, Kristina A; Copland, John A; Weroha, S John Journal: ESMO open Issue: Volume 5:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers. Issue 5 (27th October 2020) Authors: Colon-Otero, Gerardo; Zanfagnin, Valentina; Hou, Xiaonan; Foster, Nathan R; Asmus, Erik J; Wahner Hendrickson, Andrea; Jatoi, Aminah; Block, Matthew S; Langstraat, Carrie L; Glaser, Gretchen E; Dinh, Tri A; Robertson, Matthew W; Camoriano, John K; Butler, Kristina A; Copland, John A; Weroha, S John Journal: ESMO open Issue: Volume 5:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Second-line dovitinib in metastatic endometrial cancer. Issue 6 (June 2015) Authors: Block, Matthew S; Dowdy, Sean C Journal: Lancet oncology Issue: Volume 16:Issue 6(2015:Jun.) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Second-line dovitinib in metastatic endometrial cancer. Issue 6 (June 2015) Authors: Block, Matthew S; Dowdy, Sean C Journal: Lancet oncology Issue: Volume 16:Issue 6(2015:Jun.) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗